Carfilez Injection 10 mg/vial contains Carfilzomib, a proteasome inhibitor used in the treatment of multiple myeloma. It is an advanced anticancer therapy that works by disrupting protein degradation within cancer cells, leading to cellular stress and programmed cell death. It is commonly used in relapsed or refractory multiple myeloma as part of combination chemotherapy regimens.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Carfilzomib 10 mg per vial
• Dosage Form: Sterile powder for intravenous injection
• Route: Intravenous infusion only

Mechanism of Action

Carfilzomib selectively and irreversibly inhibits the 20S proteasome, preventing the breakdown of unwanted or damaged proteins inside cancer cells. This results in accumulation of toxic proteins, disruption of cellular function, and activation of apoptosis (programmed cell death), particularly in malignant plasma cells.

Indications

Carfilez Injection is indicated for:

• Relapsed multiple myeloma
• Refractory multiple myeloma
• Multiple myeloma in patients previously treated with other therapies
• Combination therapy as prescribed by an oncologist

Dosage and Administration

• Must be administered under strict oncologist supervision
• Given as intravenous infusion according to treatment protocol
• Dose is calculated based on body surface area and patient condition
• Administered in treatment cycles with close monitoring
• Hydration and supportive care may be required

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and cardiac function regularly
• Kidney and liver function should be assessed before and during treatment
• Risk of tumor lysis syndrome in high tumor burden patients
• Not recommended during pregnancy unless clearly necessary

Side Effects

Common side effects include:

• Fatigue and weakness
• Nausea and vomiting
• Fever and chills
• Shortness of breath
• Diarrhea

Serious side effects:

• Cardiac toxicity (heart failure, ischemia)
• Severe hypertension
• Kidney impairment
• Infusion-related reactions
• Serious infections due to immunosuppression

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 25°C in a cool, dry place
• Protect from light
• Reconstituted solution should be used as directed by medical staff
• Keep out of reach of children

Conclusion

Carfilez Injection 10 mg/vial (Carfilzomib) is a potent proteasome inhibitor used in the management of multiple myeloma. It works by targeting cancer cell protein regulation mechanisms, leading to tumor cell death. It must be used only under specialized oncological supervision with careful monitoring.